Press/Media
- 1 - 25 out of 53 results
Search results
-
Alzheimer's Report: Many Seniors With Memory Issues Aren't Telling Their Doctors
15/03/23
96 items of Media coverage
Press/Media
-
eFamilyCare Bolsters Advisory and Leadership Teams as Health Plans and Health Systems Demand Improved Support for Family Caregivers of Vulnerable Adults and Children
John Rowe, & Howard Fillit
22/02/23
9 items of Media coverage
Press/Media
-
-A PROMISING TRIAL TARGETS A GENETIC RISK FOR ALZHEIMER'S
2/02/23
2 items of Media coverage
Press/Media
-
Recent Regulatory Decisions Highlight Evolution of the Anti-Amyloid Theory
25/01/23
1 item of Media coverage
Press/Media
-
U.S. agency refuses to grant accelerated approval for experimental Alzheimer's treatment
24/01/23
1 item of Media coverage
Press/Media
-
-ADDF STATEMENT ON FDA DECISION NOT TO GRANT ACCELERATED APPROVAL TO DONANEMAB FOR TREATMENT OF ALZHEIMER'S DISEASE
23/01/23
2 items of Media coverage
Press/Media
-
ADDF STATEMENT ON FDA DECISION NOT TO GRANT ACCELERATED APPROVAL TO DONANEMAB FOR TREATMENT OF ALZHEIMER's DISEASE
20/01/23 → 21/01/23
89 items of Media coverage
Press/Media
-
FDA declines to grant accelerated approval for Eli Lilly's experimental Alzheimer's treatment
20/01/23
9 items of Media coverage
Press/Media
-
Regulatory roadblock for rival Alzheimer's disease treatment
20/01/23
1 item of Media coverage
Press/Media
-
ADDF Statement on FDA Decision Not to Grant Accelerated Approval to Donanemab for Treatment of Alzheimer's Disease
19/01/23
1 item of Media coverage
Press/Media
-
Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute to Support Promising Research to Protect the Alzheimer's Brain
12/01/23 → 13/01/23
142 items of Media coverage
Press/Media
-
Alzheimer's Drug Discovery Foundation And Harrington Discovery Institute To Support Promising Research To Protect The Alzheimer's Brain'
12/01/23
4 items of Media coverage
Press/Media
-
FDA Approves Second Alzheimer's Drug, Despite Safety Concerns
9/01/23
1 item of Media coverage
Press/Media
-
ADDF STATEMENT ON FDA ACCELERATED APPROVAL OF THE LECANEMAB (LEQEMBI)
9/01/23
1 item of Media coverage
Press/Media
-
FDA Approves 2nd Alzheimer’s Drug, Despite Safety Concerns
6/01/23 → 9/01/23
113 items of Media coverage
Press/Media
-
-Alzheimer's Drug Discovery Foundation ADDF STATEMENT ON FDA ACCELERATED APPROVAL OF LECANEMAB
9/01/23
2 items of Media coverage
Press/Media
-
-
U.S. FDA Approves Eisai, Biogen Alzheimer's Drug.
7/01/23 → 8/01/23
2 items of Media coverage
Press/Media
-
Eisai, Biogen get US FDA approval for Alzheimer's drug, apply for full approval
7/01/23
8 items of Media coverage
Press/Media
-
-
FDA Approves 2nd Alzheimera[euro](tm)s Drug, Despite Safety Concerns.(lecanemab)
6/01/23
1 item of Media coverage
Press/Media
-
ADDF STATEMENT ON FDA ACCELERATED APPROVAL OF LECANEMAB (LEQEMBI)
6/01/23
147 items of Media coverage
Press/Media
-
Amid criticism for its handling of another Alzheimer's drug, FDA will decide this week whether to approve lecanemab
3/01/23 → 6/01/23
5 items of Media coverage
Press/Media
-